Filing Flows › Enovix (ENVX) › Takeover & LBO
Is Enovix (ENVX) a takeover target?
A leveraged buyout does not work for Enovix on its latest figures: it has no positive EBITDA to borrow against (−$141M over the last 12 months, on revenue of $35.9M). Historically 4.8% of companies with its figures were bought within a year (0.95× the average).
Why a leveraged buyout does not fit
A leveraged buyout is paid for mostly with debt that the company's own cash flow repays. Enovix's EBITDA over the last 12 months was −$141M on revenue of $35.9M, so there is nothing to lend against and nothing to repay a loan with: a buyer would have to pay almost entirely with its own money. That is the kind of deal another company — a strategic buyer that wants the products, the pipeline or the technology — makes, not a private-equity fund. The model therefore gives no buyout price.
What a takeover could cost
Takeovers in its sector paid a median premium of 30% over the share price before the deal (the middle half 12% to 31%), according to the 14 merger proxies and tender-offer responses on EDGAR that state a premium. At the median, Enovix would cost about $3.24 a share, $707M for all its shares.
| Premium | % | Price a share | All shares |
|---|---|---|---|
| Low end (a quarter of deals paid less) | 12% | $2.79 | $609M |
| Median | 30% | $3.24 | $707M |
| High end (a quarter paid more) | 31% | $3.26 | $713M |
The odds, from history
Historically 4.8% of companies with its figures were bought within a year (0.95× the average). Its figures put it in decile 5 of 10 (10 = the most likely to be bought). The odds come from a model of every merger proxy, tender-offer response and going-private statement filed on EDGAR since 2011, set against each company's size, margins, debt, cash flow and growth the year before.
Enovix's latest quarter
Enovix, Q2 2026: revenue $9.0M (+21% year over year), operating margin -479.8%, net loss $43.1M, operating cash flow −$21.8M. The chart follows the revenue to costs, profit and cash.
Questions
Is Enovix being acquired?
No headline, 8-K or 13D about a sale is on file in the last year.
Could private equity buy Enovix?
A leveraged buyout does not work for Enovix on its latest figures: it has no positive EBITDA to borrow against (−$141M over the last 12 months, on revenue of $35.9M). With no cash flow to repay a loan, a buyer would pay almost entirely with its own money: a deal for another company (a strategic buyer), not for a private-equity fund.
What would a takeover of Enovix cost?
Takeovers in its sector paid a median premium of 30% over the share price before the deal (the middle half 12% to 31%), according to the 14 merger proxies and tender-offer responses on EDGAR that state a premium. At the median, Enovix would cost about $3.24 a share, $707M for all its shares.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.